Jazz Pharmaceuticals (JAZZ) PT Raised to $190 at Cowen, Positive on GW Deal
Tweet Send to a Friend
Cowen analyst Ken Cacciatore raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $190.00 (from $180.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
